Victory Capital Management
BIOC

Victory Capital Management’s Biocept, Inc. BIOC Stock Holding History

Victory Capital Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-73
Closed -$16K – 2580
2020
Q2 		$16K Sell
73
-49
-40% -$7.03K ﹤0.01% 2452
2020
Q1 		$10K Buy
+122
New +$12.5K ﹤0.01% 3324
2019
Q4 		– Sell
-11
Closed -$3K – 3481
2019
Q3 		$3K Buy
+11
New +$3.17K ﹤0.01% 3595

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Victory Capital Management's BIOC Position: Q3 2020 in Review

Victory Capital Management sold out of Biocept, Inc. (BIOC) in Q3 2020, closing a stake of 73 shares — an estimated $16K sold.

Victory Capital Management first reported a position in BIOC in Q3 2019 and held it in 3 quarters. The position peaked at $16K in Q2 2020. 18 funds tracked by Wall St. Rank hold BIOC as of Q3 2020.

  • Victory Capital Management reported no remaining Biocept, Inc. position as of Q3 2020 after selling out during the quarter.
  • Victory Capital Management sold 73 Biocept, Inc. shares in Q3 2020, an estimated $16K.
  • Victory Capital Management first reported a position in Biocept, Inc. in Q3 2019 and held it in 3 quarters.
  • Victory Capital Management's Biocept, Inc. position peaked at $16K in Q2 2020.
  • 18 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2020.

Based on Victory Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.